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Abstract: In recent years, three-dimensional mesoscopic imaging has gained significant
importance in life sciences for fundamental studies at the whole-organ level. In this manuscript,
we present an optical projection tomography (OPT) method designed for imaging of the intact
mouse brain. The system features an isotropic resolution of ~50 µm and an acquisition time of four
to eight minutes, using a 3-day optimized clearing protocol. Imaging of the brain autofluorescence
in 3D reveals details of the neuroanatomy, while the use of fluorescent labels displays the vascular
network and amyloid deposition in 5xFAD mice, an important model of Alzheimer’s disease
(AD). Finally, the OPT images are compared with histological slices.
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1. Introduction
Since its invention in the 19th century, histopathology has been and continues to be a widely
used method for tissue-based medical diagnosis. While it excels at producing two-dimensional
images of tissue sections, extracting information from whole three-dimensional tissues remains
challenging. As a complement to histopathology, a new imaging regime, termed mesoscopy [1]
emerged at the beginning of the century for 3D visualization of samples spanning a scale from a
few millimeters to several centimeters. Over time, various techniques have been developed within
this regime.
Micro-optical sectioning tomography (MOST) [2] is a block-face imaging method where the
process of histology is automatized via simultaneous imaging and sectioning of the tissue. This
technique has been successfully applied to image a whole mouse brain with a submicrometric res-
olution [3]. However, the acquisition time of approximately two weeks represents an experimental
limitation for studies involving numerous animals.
Light-sheetmicroscopy [4] is probably themost prolific example of thesemesoscopic techniques.
Light-sheet microscopy performs three-dimensional imaging by scanning an engineered sheet of
light orthogonal to the optical axis. This illumination mechanism achieves optical sectioning
without slicing the tissue along with minimal photobleaching. The penetration depth of light-sheet
microscopy is enhanced in naturally-transparent or cleared samples due to the reduction in
light scattering. Recent research on light-sheet microscopy has mainly been focused on in vivo
imaging. Improved illumination strategies (for example with optical lattices [5]), and solutions
for specimen mounting in a physiological environment [6] have been developed. Additionally,
the combination of light-sheet microscopy with structured illumination microscopy has increased
the visibility through opaque samples [7], thus avoiding optical clearing (a process often done
ex vivo due to its toxicity). Efforts have also been directed towards imaging larger samples,
such as entire neural [8] and vascular networks [9, 10], or Alzheimer’s disease (AD) hallmark
amyloid deposition [11] in whole mouse brains. These particular results have helped to establish
light-sheet microscopy as a tool for mouse phenotyping and investigations of disease models.
Light-sheet microscopy produces outstanding 3D image quality with subcellular resolution over
large volumes, which typically translates into big data sets. These require excessively long image
processing time and terabytes of data handling [12]. Moreover, the optical design and image
processing pipeline of such systems can be complex for inexperienced users. For these reasons,
we propose optical projection tomography (OPT) as an alternative.
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OPT is a three-dimensional imaging technique developed by James Sharpe in 2002 [13] for 3D
microscopy and gene expression studies. Considered as an optical analogue of X-ray computed
tomography (CT) [14], OPT allows sample reconstruction from projections acquired at different
angles. These projections are images taken over 360◦, by rotating the sample, with a depth of
field (DOF) covering half the specimen. Depending on the illumination, the projections either
provide information on the light absorption or the integration of a fluorescence signal through
the sample [15]. In both cases, the reconstruction of inner structures strongly depends upon the
sample’s transparency. For enhanced penetration depths, OPT requires naturally-transparent or
cleared samples. Recently, custom OPT systems have been developed [16], including helical
OPT [17], where a vertical translation is introduced during the acquisition process to enable
imaging of elongated samples, such as rodent spinal cords and large intestines. Along with these
hardware improvements, OPT benefited from several artifact-correction [18] and resolution
improvement [19] algorithms. For example, to automatically recover the center of rotation (COR)
in the projections [20] or to account for fluorescence absorption in tissues with a normalized
Born approach [21]. Additionally, accelerated reconstruction procedures have been achieved
by taking advantage of either iterative algorithms [22], or parallel processing on the graphics
processing unit (GPU) [23]. Various applications highlight the performance of OPT. These include
in vivo imaging of the zebrafish vasculature [24], fruit fly pupae head eversion process [25],
morphogenesis of salivary glands and wing imaginal discs [26], as well as fluorescence lifetime
in living zebrafish embryos [27], and visualization of plant development [28, 29]. Furthermore,
OPT has been used for whole organ imaging in mice to study the pancreas and beta-cell tissue
in the development of diabetes [30, 31], the spinal cord and optic nerve in the development
of experimental autoimmune encephalomyelitis (EAE) [32], and to perform neuroanatomical
phenotyping [33, 34]. So far, OPT is limited in resolution by the depth of field required for
imaging. However, its rapidity and simplicity in image acquisition and processing make OPT
convenient for various routine applications.
In this paper, we present a novel OPT methodology for whole mouse brain imaging. It includes
an OPT design which uses the principle of epifluorescence, a feature known to maximize the
rejection of stray light and homogenize the illumination in the sample plane. In addition to the
setup design, we provide an outline of the software processing and demonstrate 3D imaging of
the brain with an optimized solvent-based clearing protocol. A dehydration step of a single day in
100 % methanol with one refresh in the clearing protocol is shown to be sufficient to reveal details
of the mouse neuroanatomy (while several days and increasing concentration of solvent solution
were previously required [8, 11, 33]). Furthermore, our sample preparation has been successfully
combined with different standard labeling protocols from fluorescence imaging technology to
image the vasculature of wild-type mouse brains as well as the distribution of amyloid plaques
in the brain of transgenic mice that coexpress five familial AD mutations (5xFAD mice) [35],
an important model of the disease. Finally, we show a comparison of the OPT images with
histological slices from the same mouse brain.
2. Materials and methods
2.1. Optical projection tomography
Our mesoscopic OPT setup (Fig. 1) is designed for 3D imaging of whole intact mouse brains. As
shown in blue in Fig. 1(A) and 1(B), the detection arm consists of a 4f systemwith an objective lens
Lo (f = 300 mm, AC508-300-A-ML, Thorlabs) and a tube lens Lt (f = 150 mm, AC508-150-A-ML,
Thorlabs), both achromatic. This configuration results in a 0.5X magnification on the detector
(ORCA-Flash 4.0 V2, Hamamatsu), providing a field of view (FOV) of 26.6 × 26.6 mm2 over
1024 × 1024 px2 in a 2 × 2 binning mode (initially 2048 × 2048 px2). A DOF of approximately
15 mm (according to the definition of Inoué and Spring [36], equation 2.18) is obtained by placing
a 4 mm diameter diaphragm in the rear focal plane of the objective lens, which also makes the
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system telecentric. The resulting numerical aperture (NA) of 0.01 provides a diffraction-limited
lateral resolution of 28 µm (according to the definition of Inoué and Spring [36], equation 2.7).
However, this diffraction-limited lateral resolution is currently hindered by the pixel-limited
resolution of 52 µm (twice the binned pixel size). The projections are captured at angular steps
of 0.3◦ (or 0.9◦ in Fig. 6(E)) by rotating the sample over 360◦ i.e., 1200 projections (or 400
projections in Fig. 6(E)), in a step-and-shoot mode. The reconstruction of samples as thick as
26 mm (limited by the FOV) is typically achieved within minutes (see Table 1 for details on
exposure and acquisition time). As illustrated in green in Fig. 1(A), the sample is illuminated
by switchable LEDs. In this manuscript, we use a 420 nm LED (M420D2, Thorlabs) and a
470 nm LED (M470D2, Thorlabs), also described in Table 1. These LEDs are collimated by
an aspheric lens Lc (f = 16 mm, ACL25416U, Thorlabs). The resulting illumination beam
is magnified by another 4f system composed of an achromatic relay lens Lr (f = 150 mm,
AC254-150-A-ML, Thorlabs) and the objective lens, providing a uniform full-field illumination
of the sample plane while maximizing the rejection of stray light. A kinematic fluorescence filter
cube (DFM1/M, Thorlabs) is used to introduce and filter the illumination beam in the detection
path (epifluorescence), and a modular LED switching mechanism (Fig. 1(C)) allows the user to
choose between different fluorescence configurations (described in Table 1).
Table 1. OPT configuration to visualize different features of interest. Stated are LEDs, filters,
exposure time, and total acquisition time. Filters references are from Chroma: EX, excitation
filter; DC, dichroic mirror; EM, emission filter.
Feature Figure LED Filters Exposure Acquisition(marker) time [s] time [min]
neuroanatomy
(autofluorescence) 3 420 nm
EX, AT420/40x
0.2 4DC, AT455dc
EM, AT465lp
vascular network
(FITC-albumin hydrogel) 4, 6(B)-(C) 470 nm
EX, AT480/30x
0.2-0.4 4-8DC, AT505dc
EM, AT535/40m
amyloid plaques
(Methoxy-X04) 5, 6(E) 420 nm
EX, AT420/40x
0.15-0.3 3-6DC, AT455dc
EM, AT465lp
Before imaging, the sample embedded in agarose is glued (Loctite 454, Loctite) on a holder
and attached to a motorized rotation stage (8MR190-2, Standa) using a magnet, as depicted in
Fig. 1(D). The OPT imaging takes place across a cuvette (704-001-30-10, Hellma Analytics)
filled with a 1:2 mixture of benzyl alcohol and benzyl benzoate (BABB) for index matching.
Three motorized linear stages (8MT167-100, Standa) provide additional degrees of freedom for
aligning and focusing the sample. We use the translation along the y-axis to align the rotation axis
on the center of the detector, and the magnet to align the sample gravity center on the rotation
axis. These alignment procedures are necessary to keep the sample within the FOV of the setup
but can be carried out approximately since the COR is numerically retrieved in the reconstruction
algorithm. The tilt of the rotation axis has been minimized by precisely manufacturing the custom
components and does not significantly affect the reconstruction process. More control on this
parameter can be achieved by adding a tip-tilt mount on the rotation stage and using the alignment
protocol described by Wong et al. [16].
2.2. Image processing
As illustrated in Fig. 2, image acquisition with the OPT system produces a stack of 1200 or
400 projections, separated by the same angular distance and depicting the sample over 360◦.
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Fig. 1. OPT design. The optical layout (A) and the corresponding CAD rendering (B)
illustrate the detection (blue) and illumination (green) arms. A detailed view of the LEDs
mount (C) demonstrates the system for alignment and switching. It is composed of a custom
heat sink (yellow), a spring (red, C.254.250.0250.A, Vanel), and a ring (blue, SM1RR,
Thorlabs) stacked inside a 1-inch tube (SM1L20, Thorlabs) and screwed to a quick-release
translation mount (CXY1Q, Thorlabs). The custom sample holding mechanism (D) consists
of a base tube (yellow) glued to a magnet (green) to hold the magnetic stainless steel cylinder
(red). The sample is glued to the blue cylinder which can be screwed to the whole mechanism.
These projections are pre-processed with Fiji [37] depending on the sample preparation. Brain
autofluorescence reconstructions sometimes present ring artifacts [18], presumably due to a
variation in the pixels response of the camera. A median filter (3 × 3, radius 0.5 px) is applied
to the projections to mitigate this effect. Vasculature-labeled brain reconstructions display an
increased contrast by applying a mean filter of the same size to the projections. No pre-processing
step is applied to amyloid-labeled brain projections. A line is fit on the maximum values of
the convolution of the first projection I0◦ with the opposite projection I180◦ along the vertical
direction. This line forms a vector containing the CORs (shown with a green dotted line in Fig. 2),
for each vertical position in the projection stack. These COR values are crucial to avoid artifacts
in the reconstruction. The projection stack is transformed into a sinograms stack, by permuting
the dimensions of the stack, and each sinogram is high-pass filtered with a Shepp-Logan filter. A
3D image of the sample is obtained by back-projecting each sinogram around the corresponding
COR value with a linear interpolation. The sinograms’ filtering and back-projection compose
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the conventional filtered back-projection (FBP) algorithm [14] and are implemented in CUDA
(Nvidia) to take advantage of massive parallelization on the GPU. A desktop computer operated
with Windows 7 Enterprise SP1 64-bit (Microsoft) and equipped with two Xeon CPU E5-2650 v2
(Intel), 64 GB DDR3 RAM, a GeForce GTX TITAN Black embedding 2880 CUDA cores, and
6 GB GDDR5 memory allows processing the samples in approximately 2 minutes for a resulting
8-bits stack of 1024 x 1024 x 1024 px3 (around 0.5 GB in size). Finally, three-dimensional image
rendering is performed with the Imaris (Bitplane) software.
Image acquisition
(projections)
Pre-processing
=*
Center of rotation retrieval
CORI0° I180°
1024 px
10
24
 p
x
1200
Sinograms filtering
1200 px
1024
10
24
 p
x
1024 px
10
24
 p
x
10
24
Back-projection
Filtered back-projection
(GPU implementation)
Rendering
Fig. 2. Image processing pipeline illustrating the filtered back-projection (FBP) as well as
the automatic retrieval of the COR algorithms. After a pre-processing step (described in
text), the sinograms are filtered and the corresponding COR is retrieved. Following these
operations, the sinograms are back-projected to form the virtual tissue sections, and 3D
rendering is applied.
2.3. Mouse model
5xFAD genetically-modified mice [35] were purchased from The Jackson Laboratory on a
congenic C57BL/6J background (34848-JAX, MMRRC). They were bred and maintained in-
house with SJL/J mice (000686, The Jackson Laboratory) to generate the experimental animals
on a hybrid B6SJL F1 background, which demonstrates a more robust amyloid phenotype. This
model of AD is extensively used in research and displays many of the phenotypes associated
with the disease [35]. In particular, the mice are known to develop an early and severe amyloid
deposition starting from 1.5 months of age [35].
2.4. Sample preparation
All animal procedures were carried out according to Swiss regulations under the approval of the
veterinary authority of the canton of Vaud.
Amyloid plaques labeling. Similar to the protocol reported by Jährling et al. [11], 5xFADmice
and their littermate controls, on a B6SJL F1 background, received two consecutive intraperitoneal
(IP) injections of 30 mg/kg Methoxy-X04 (Tocris) in DMSO (10 mg/ml) with a 24-h interval.
During the second injection, 100 µl (30 µg/ml) buprenorphine in 0.9%NaCl was also administered
subcutaneously (SC) for analgesia. Two hours later, the animals were deeply anesthetized IP with
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sodium pentobarbital (150 mg/kg) in aqueous solution (150 mg/ml). Once the depth of anesthesia
was sufficient (assessed with toe pinch reflex), the animals were transcardially perfused with
2 ml of heparinized (5 I.U./ml) 1X PBS (pH 7.4), followed by 15 ml of 10 % formalin solution
(HT501128, Sigma), at 4◦ C and 1.5 ml/min, for tissue fixation. After the perfusion, the brains
were extracted and postfixed in 40 ml of formalin at 4◦ C overnight.
Vasculature labeling. B6SJL F1 mice were anesthetized as described above (including the
injection of buprenorphine). Subsequently, an identical transcardial perfusion was performed with
the additional 10 ml of hydrogel [10] at 40◦ C and 1.5 ml/min. The hydrogel is a mixture of 2 %
(w/v) gelatin (G1890, Sigma) in 1X PBS (prepared at 60◦ C) and 0.1 % (w/v) FITC-conjugated
albumin (A9771, Sigma) done at 40◦ C (0.22 µm-filtered). Before organ harvesting and fixation
(as described above), the mouse head was incubated in ice-cold water for 10 minutes to solidify
the hydrogel.
Organ clearing. After fixation, the organs were mounted in 1.5 % (w/v) agarose (16500500,
Invitrogen) at 45◦ C with Milli-Q water (0.22 µm-filtered and degassed) and dehydrated in 40 ml
of 100 % methanol (ME03161000, Scharlau) on a rotator (10 RPM) for 24 h with a renewal
of the methanol after 15 h. Similar results (not shown here) were obtained by dehydration
in ethanol. Then, the organs were transferred to a 40 ml solution of BABB (148390010 and
105860010, ACROS Organics) for optical clearing. This process can last for several days, but
after approximately 48 h, the brain transparency is sufficient for imaging.
Histology. After fixation, the brains were split into hemispheres. One hemisphere was cleared
and imaged with OPT. The other hemisphere was transferred to a 40 ml solution (0.22 µm-filtered)
of 30 % (w/v) sucrose in 1X PBS (pH 7.4) at 4◦ C for approximately 48 h, or until the sample
sunk at the bottom of the tube. Then the sample was partially dried on a tissue, placed in an
embedding mold (such as 27112, Ted Pella Inc), and immersed in Cryomatrix (6769006, Thermo
Scientific). Following the immersion in Cryomatrix, the mold was dipped in a bath of isopentane
(avoid contact between Cryomatrix and isopentane) and dry ice until the Cryomatrix became
completely opaque. Afterwards, the samples were stored at -80◦ C before slicing, with a sliding
microtome, and mounting. The hemisphere sections were imaged on an Apotome (Zeiss) with a
5X, 0.15 NA air-objective, as well as a DAPI and wtGFP filter sets (for plaques and vasculature
respectively). The Fiji plugin MosaicJ [38] was used to stitch the Apotome images together and
create an image of the whole section.
3. Results and discussion
3.1. Neuroanatomy
To demonstrate the performance of our novel OPT approach, we started by clearing 2- to
8-month-old B6SJL F1 mouse brains (n>5). Figure 3(A) shows a representative image of a
cleared brain at the age of 8 months. The transparency is sufficient to see through the organ and is
adequate for OPT imaging (see Fig. 3(B) and 3(C)). Standard BABB clearing techniques require
tissue immersion in increasing series of methanol concentration for dehydration to prevent cellular
distortions and excessive shrinkage of the tissue. However, we found that it is not needed for OPT
as the agarose embedding acts as a protective coating. The samples are directly dehydrated in
100 % methanol, and this simplifies the clearing protocol. Although not shown in Fig. 3, we
observed shrinkage of the organs, a known side-effect of BABB clearing [39].
Images of the same 8-month-old brain were further acquired using the OPT system with
the 420-nm excitation illumination, and a 3D rendering is shown in Fig. 3(B). With its 0.5X
magnification and 15-mm DOF, the setup successfully captures the whole three-dimensional
nature of the organ. Individual coronal sections (Fig. 3(C)) reveal details of the neuroanatomy
down to the deepest structures. For example, the lateral (vl) and third (v3) ventricles are cavities
in the brain, which get filled with BABB and therefore appear as dark regions in the sections. The
caudoputamen (cp), identified through its sponge-like structure, and the thalamus (th), appear
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brighter. More brain regions can be identified via the different autofluorescence contrasts, such
as the cortex (ctx), culmen (cul), and medial mammillary nucleus (mm), which present a higher
contrast, the optic chiasms (och), which appear as a bright tube with a dark, presumably hollow,
core, but also the corpus callosum (cc), the hippocampal region (hip), the inferior colliculus
(ic), and the central lobule (cent). The identification of these different brain regions using the
autofluorescence contrast confirms the ability of our OPT system to perform neuroanatomical
phenotyping as described previously [33].
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A B C
Fig. 3. Photograph of a mounted and cleared 8-month-old B6SJL F1 mouse brain (A). 3D
rendering of the OPT image obtained from tissue autofluorescence (B, Visualization 1).
Single coronal sections of the OPT image (C) showing the inner morphology of the intact
organ: cc, corpus callosum; cent, central lobule; cp, caudoputamen; ctx, cerebral cortex; cul,
culmen; hip, hippocampal region; ic, inferior colliculus; mm, medial mammillary nucleus;
och, optic chiasm; p, pons; th, thalamus; v3, third ventricle; vl, lateral ventricle. Grid spacing
(in A): 1 cm. Scale bars: 1 mm.
3.2. Vascular network
Vascular abnormalities play an important role in cognitive decline and inflammation in some
AD patients. To demonstrate the compatibility of our clearing protocol with a fluorescence
labeling of the vasculature, we perfused the animals with an FITC-albumin hydrogel. This
labeling method was performed on 4-month-old B6SJL F1 mouse brains (n=2) and the resulting
images, acquired using the OPT system with the 470-nm excitation illumination, are shown in
Fig. 4. In this configuration, we can identify a variety of vascular compartments, including the
superior sagittal sinus (SSS) and the sigmoid sinus (SS), which are venous sinuses found within
the dura mater, the outermost layer surrounding the central nervous system, and located on top
of the brain (Fig. 4(A)). The caudal rhinal vein (CRV), running on the side of the brain in a
sagittal manner (Fig. 4(B)), the anterior cerebral artery (ACA), which partly forms the circle
of Willis, ring-shaped system of arteries, situated at the base of the brain (Fig. 4(C)), and the
middle cerebral artery (MCA) traveling from the circle of Willis to the top of the brain. To better
appreciate the 3D nature of the blood vessels, we created maximum intensity projections from 20
consecutive OPT sections at different positions of the brain (Fig. 4(D)). These artificial sections
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represent half a millimeter of the whole brain sliced coronally and highlight penetrating vessels
several millimeters in depth. However, smaller vessels, such as capillaries, have a diameter of
typically less than 10 µm and fall beyond our resolution limit. The innermost vessels of the
brains are seemingly undetected. This could be due to the depletion of the fluorescence signal
propagating through the sample as well as the shadowing from the surface vasculature. Ultimately,
the identification of large brain vessels with the hydrogel perfusion extends the phenotyping
capacity of OPT and has potential application in the study of aneurysms, strokes, and vascular
development [40].
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Fig. 4. Visualization of the brain vasculature in a 4-month-old B6SJL F1 mouse. The brain
was perfused with an FITC-albumin hydrogel and imaged with OPT. 3D rendering from the
top (A), side (B), and bottom (C) view (see Visualization 2). Maximum intensity projections
of 20 coronal sections through the whole brain (D) showing the penetrating venules/arterioles.
ACA, anterior cerebral artery; CRV, caudal rhinal vein; MCA, middle cerebral artery; SS,
sigmoid sinus; SSS, superior sagittal sinus. Scale bars: 1 mm.
3.3. Amyloid deposition
New amyloid imaging agents, based on the chemical structure of histologic dyes, are now making
it possible to track amyloid pathology along with disease progression. To show the compatibility
of our clearing protocol with fluorescence labeling of amyloid deposits, we injected the animals
IP with an amyloid-binding dye called Methoxy-X04. This labeling method was performed
on 8-month-old 5xFAD mouse brains (n=3) and the resulting images, acquired using the OPT
system with the 420-nm excitation illumination, are shown in Fig. 5. Individual sections of the
three-dimensional OPT image (Fig. 5(A)) reveal a mixed contrast between the brain anatomy
and amyloid plaques, seen as bright dot agglomerates (denser zones pointed out by the arrows),
caused by the overlap of the autofluorescence and the Methoxy-X04 emission spectra. The 3D
rendering of the whole brain, presented in Fig. 5(B), reveals the amyloid distribution in the organ
and highlight an important aggregation in the subiculum (Fig. 5(B) and 5(C)). This result adds to
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the findings of Oakley et al. [35], who used histology to localize amyloid deposition, providing
deeper insights into the 3D distribution of the amyloid plaques. Interestingly, the pathological
phenotype observed in the 5xFAD mice shows differences in the 3D distribution compared to the
APPPS1 model used in the work of Jährling et al. [11] at a comparable age. This observation
further demonstrates the high potential of OPT for fast phenotyping. Small plaques (below 50 µm)
are blurred out due to the system’s resolution.
A B C
Fig. 5. 3D imaging of amyloid deposition in an 8-month-old 5xFAD mouse. Single coronal
sections (A) with the arrows pointing to regions with high deposition and three-dimensional
rendering of the OPT image (B, Visualization 3). A 3D image of the subiculum (green) is
shown within a whole mouse brain (C) to compare with the location of amyloid deposition.
Image (C) was obtained from the Allen mouse brain atlas [41]. Scale bars: 1 mm.
3.4. Histology comparison
The proposed framework for rapid mouse brain imaging with OPT extends the current 3D
capability of traditional histology. For this reason, we performed a qualitative comparison of
both techniques by splitting labeled mouse brains into hemispheres. The hemispheres were then
processed separately: one was prepared for histology (Fig. 6(A) and 6(D)), and the other one for
OPT (Fig. 6(B)-(C) and 6(E)).
First, the result of this comparison for the vasculature in a 9-month-old B6SJL F1 mouse brain
is shown in Fig. 6(A)-(C). The histological slice (Fig. 6(A), Visualization 4) displays details of
the microvasculature as well as larger vessels, pointed by pink arrows. However, the acquisition
and stitching of the images took almost an hour for a single section. Additionally, stitching
artifacts, such as the one pointed by the blue arrow, remain visible in the figure. On the other
hand, some of the large vessels (pink arrows) can be identified in the OPT section (Fig. 6(B)), but
the microvasculature is not resolved. Additionally, we used the 3D capability of OPT to produce
a maximum intensity projection (Fig. 6(C)) from 20 consecutive sections (approx. 0.5 mm in
thickness), which reveals a range of penetrating vessels otherwise difficult to obtain in histology.
Second, the result of the comparison for the amyloid plaques in a 3-month-old 5xFAD mouse
brain is shown in Fig. 6(D)-(E). The histological slice (Fig. 6(D), Visualization 5) present a
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high-resolution mixed contrast between tissue autofluorescence and amyloid plaques (regions of
accumulation pointed by green arrows). However, the acquisition and stitching took approximately
an hour, and the resulting section suffers from microtome artifacts (blue arrows). On the other
hand, the regions of plaques accumulation (green arrows) could be retrieved in the OPT section
(Fig. 6(E)) with a lower resolution. Additionally, we observed an opposed contrast in some
regions of the brain, such as the corpus callosum (cc), which is bright in the histological section
but appears dark in OPT. This might be caused by the chemical clearing.
These results highlight the complementarity of traditional histology and OPT. Mechanical
slicing associated with wide-field fluorescence microscopy produces high-resolution images of
the features of interest in 2D. However, this method can be cumbersome (particularly the cutting
and stitching parts) and is hardly suitable for 3D imaging. On the other hand, OPT produces
low-resolution 3D images of the whole organ in about 5 minutes with a user-friendly sample
preparation.
A B C
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Fig. 6. Comparison of histological and OPT slices. 40 µm-coronal section of a 9-month-
old B6SJL F1 mouse brain hemisphere labeled for vasculature (A, Visualization 4) and
corresponding single OPT section (B). A maximum intensity projection (C) taken over
20 consecutive OPT sections, which represents approximately 0.5 mm in thickness, gives
a better representation of the penetrating vessels and highlights the 3D advantage of this
technique. 40 µm-coronal section of a 3-month-old 5xFAD mouse brain hemisphere labeled
for plaques (D, Visualization 5) and corresponding single OPT section (E), some regions
such as the corpus callosum (cc) show an inverted contrast. Scale bars: 2 mm.
4. Conclusion
In this manuscript, we present a novel OPT method for whole mouse brain imaging. This method
is based on a custom OPT system, designed for mouse brain imaging, and an optimized sample
preparation. The OPT system provides an FOV of 26.6 x 26.6 mm2 and can image samples as
thick as 26 mm typically within less than 5 minutes. It incorporates an epifluorescence arm,
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which provides a uniform full-field illumination and is easily configurable by switching the
excitation LEDs and filters. The sample preparation consists of a simple and rapid solvent-based
clearing of the organ (3 changes of clearing solution in 3 days). This can be complemented with
fluorescence labeling of the vasculature, through perfusion of a fluorescent hydrogel, or labeling
of amyloid deposition in a mouse model of AD, via 2 consecutive injections of an amyloid-binding
dye. Based on this method, we imaged B6SJL F1 mouse brains without markers. The results
demonstrate the quality of the clearing and reveal details of the organ structure, an essential
requirement of neuroanatomical phenotyping [33]. Additionally, by imaging the vasculature of
B6SJL F1 mouse brains, we identify major vessels, as well as penetrating arterioles/venules in
3D down to several millimeters in depth. We also imaged 5xFAD mouse brains with labeled
amyloid deposition. Individual sections of the OPT image revealed regions of accumulated
amyloid plaques. Through 3D rendering, we could identify the subiculum as the region with the
densest accumulation, in concordance with the literature [35]. Finally, we performed a qualitative
comparison of histological and OPT slices in the different hemispheres of the same brain to
illustrate the complementarity of these two techniques.
The rapid acquisition of whole mouse brains with our OPT system is achieved through a long
DOF and a low magnification, which currently limit the resolution to ~50 µm. Additionally,
the low NA of the system restricts the light collection efficiency. This would be a plausible
explanation for why finer structures such as capillaries and small amyloid plaques (<50 µm)
were undetectable. Furthermore, the method requires embedding of the sample in agarose for
mounting purposes. While the surrounding agarose simplifies the clearing protocol, by creating
an interface with the solvents and avoiding the use of increasing concentration solutions, it has
not been tested yet with other clearing methods such as CLARITY [42], SeeDB [39], Scale [43],
or 3DISCO [44].
In the future, other clearing methods optimized for OPT might improve the current results
obtained with BABB; new amyloid imaging agents with a distinct excitation/emission spectrum
will help to discriminate between the tissue autofluorescence and the amyloid plaques. Additionally,
our imaging method shows high potential for the use in neuropathology and the study of disease
progression, similarly to the work and research in diabetes [30, 31], by imaging the mouse
pancreas at different ages. Ultimately, our OPT setup with its large FOV is well suited for the
imaging of other organs, such as the liver, lung, and kidney.
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